Natural Products in Drug Discovery in the 21st Century: Challenges and Opportunities

A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Natural Products".

Deadline for manuscript submissions: closed (25 April 2025) | Viewed by 933

Special Issue Editor

Special Issue Information

Dear Colleagues,

The search for novel therapeutic agents has been an enduring quest in the field of medicine and pharmaceutical sciences. One promising strategy for drug discovery and development is the exploration of biodiversity, which has played an essential role in the development of numerous drugs. Moreover, natural products are also of the utmost importance in traditional medicine, being the basis of primary health care systems, particularly in developing countries. Furthermore, we are now observing an increasing consumption of natural-product-based supplements from botanical and marine sources, making their standardization and comprehensive scientific validation a priority to guarantee the safe use of these products. Consequently, over the past few decades, there has been a resurgence of interest in natural product research, both within the scientific community and the pharmaceutical industry. Earth's biodiversity offers an amazing collection of unique chemical structures that are difficult to replicate synthetically. The chemical diversity, historical successes, drug-like properties, and potential for novel mechanisms of action make natural products an indispensable resource and an invaluable opportunity for drug discovery.

This Special Issue, “Natural Products in Drug Discovery on the 21st Century: Challenges and Opportunities”, aims at gathering both original articles and comprehensive reviews related to research on natural products, focusing on their vital role in drug discovery. Topics of interest include, but are not limited to, the following: the isolation and structural elucidation of bioactive compounds; in vitro or in vivo biological activities of secondary metabolites, along with their mechanism of action and/or possible applications; synthetic strategies for natural metabolites and/or analogs; hemi-synthesis of natural product derivatives with improved bioactivity; bioactivity of medicinal plant extracts and development of medicines; biological and pharmacological applications; essential oils with pharmaceutical interest; bioactive compounds against neglected tropical diseases; and infectious diseases and cancer.

Dr. Noelia Duarte
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • natural products
  • bioactive natural compounds
  • marine drugs
  • medicinal plants
  • in vitro and in vivo biological activity
  • pharmacological activity
  • drug discovery
  • medicinal and technological applications
  • medicinal chemistry

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

23 pages, 1895 KiB  
Article
Polyphenolic Composition, Mineral Profile, and Biological Activities in Different Organs of Alpine Woundwort—Insights into Antioxidant and Enzyme Inhibitory Potential
by Sabina Lachowicz-Wiśniewska, Ireneusz Ochmian, Jan Oszmiański, Rafał Wiśniewski, Małgorzata Bernatek, Paweł Rubiński and Daniela De Vita
Pharmaceuticals 2025, 18(5), 674; https://doi.org/10.3390/ph18050674 - 1 May 2025
Viewed by 272
Abstract
Background: Stachys alpina is a medicinal plant from the Lamiaceae family whose biological potential remains poorly explored. Methods: The aim of this study was to comprehensively assess the pol-yphenol profile, macro- and microelement composition, and the antioxidant, an-ti-diabetic, and anti-obesity activities of [...] Read more.
Background: Stachys alpina is a medicinal plant from the Lamiaceae family whose biological potential remains poorly explored. Methods: The aim of this study was to comprehensively assess the pol-yphenol profile, macro- and microelement composition, and the antioxidant, an-ti-diabetic, and anti-obesity activities of various plant organs (leaves, flowers, stems, and roots). Results: The leaves and flowers exhibited the highest concentration of phenolic compounds, while anthocyanins were detected exclusively in the flowers (215.05 mg/100 g dry matter (dm)) and constituted 3% of the total polyphenols. Verbas-coside and chlorogenic acid were the most abundant polyphenols, reaching 4618.88 and 3277.83 mg/ 100 g dm in the leaves. The highest ABTS and FRAP scavenging activity was observed in leaves (19.30 and 7.62 mmol TE/g dm, respectively). Principal component analysis demonstrated a strong correlation between polyphenol content and antioxidant activity (ABTS-r= 0.87 and FRAP-r = 0.90), which was further confirmed by Pearson’s correlation coefficients. The study also highlighted the significant impact of mineral composition on biological activity—calcium and magnesium dominated in stems (10,100 and 3900 mg/kg) and in roots (9200 and 3100 mg/kg), supporting the functioning of an-tioxidant enzymes, while zinc and manganese in leaves (89.43 and 155.33 mg/kg) con-tributed to intense metabolic processes. Conclusions: S. aplina could serve as a valuable source of natural antioxidants and enzyme inhibitors associated with glucose and lipid metabolism, suggesting its promising application in the prevention and management of metabolic disorders.. Full article
Show Figures

Figure 1

Back to TopTop